Faculté de Médecine - Secteur Timone, EA 3279: CEReSS -Centre d'Etude et de Recherche sur les Services de Santé et la Qualité de vie, Aix-Marseille Univ., 27 Boulevard Jean Moulin, 13005, Marseille, France.
Department of Epidemiology and Health Economics, APHM, Marseille, France.
Sci Rep. 2021 May 13;11(1):10167. doi: 10.1038/s41598-021-89726-y.
Little is known on the end-of-life (EOL) care of terminal breast cancer in women with severe psychiatric disorder (SPD). The objective was to determine if women with SPD and terminal breast cancer received the same palliative and high-intensity care during their end-of-life than women without SPD. Study design, setting, participants. This population-based cohort study included all women aged 15 and older who died from breast cancer in hospitals in France (2014-2018). Key measurements/outcomes. Indicators of palliative care and high-intensity EOL care. Multivariable models were performed, adjusted for age at death, year of death, social deprivation, duration between cancer diagnosis and death, metastases, comorbidity, smoking addiction and hospital category. The analysis included 1742 women with SPD (287 with bipolar disorder, 1075 with major depression and 380 with schizophrenia) and 36,870 women without SPD. In multivariate analyses, women with SPD had more palliative care (adjusted odd ratio aOR 1.320, 95%CI [1.153-1.511], p < 0.001), longer palliative care follow-up before death (adjusted beta = 1.456, 95%CI (1.357-1.555), p < 0.001), less chemotherapy, surgery, imaging/endoscopy, and admission in emergency department and intensive care unit. Among women with SPD, women with bipolar disorders and schizophrenia died 5 years younger than those with recurrent major depression. The survival time was also shortened in women with schizophrenia. Despite more palliative care and less high-intensity care in women with SPD, our findings also suggest the existence of health disparities in women with bipolar disorders and schizophrenia compared to women with recurrent major depression and without SPD. Targeted interventions may be needed for women with bipolar disorders and schizophrenia to prevent these health disparities.
关于患有严重精神障碍 (SPD) 的晚期乳腺癌女性的临终关怀知之甚少。目的是确定患有 SPD 和晚期乳腺癌的女性在临终前是否与没有 SPD 的女性一样接受姑息治疗和高强度护理。研究设计、设置和参与者。这项基于人群的队列研究包括在法国医院死于乳腺癌的所有 15 岁及以上的女性(2014-2018 年)。主要测量/结果。姑息治疗和高强度临终关怀的指标。进行了多变量模型分析,调整了死亡时的年龄、死亡年份、社会贫困程度、癌症诊断与死亡之间的时间间隔、转移、合并症、吸烟成瘾和医院类别。该分析包括 1742 名患有 SPD 的女性(287 名患有双相情感障碍、1075 名患有重度抑郁症和 380 名患有精神分裂症)和 36870 名没有 SPD 的女性。在多变量分析中,患有 SPD 的女性接受姑息治疗的比例更高(调整后的优势比 aOR 1.320,95%CI [1.153-1.511],p<0.001),在死亡前接受姑息治疗的时间更长(调整后的β=1.456,95%CI [1.357-1.555],p<0.001),化疗、手术、影像学/内窥镜检查、以及急诊和重症监护病房的入院治疗更少。在患有 SPD 的女性中,双相情感障碍和精神分裂症的女性比复发性重度抑郁症的女性早 5 年死亡。精神分裂症女性的生存时间也缩短了。尽管患有 SPD 的女性接受了更多的姑息治疗和较少的高强度治疗,但我们的研究结果也表明,与复发性重度抑郁症且没有 SPD 的女性相比,双相情感障碍和精神分裂症女性存在健康差异。可能需要针对双相情感障碍和精神分裂症女性的针对性干预措施,以预防这些健康差异。